Amethyst Radiotherapy Austria, one of the world’s leading private practices in the field of radiation oncology, has been featured by top Serbian medical portal e-Klinika, celebrating its achievements in the provision of radiotherapy services to oncology patients over the last 15 years.

The Power of Radiotherapy

Radiotherapy itself is one of the most effective forms of cancer treatment, with more than 50 per cent of patients undergoing radiotherapy during their cancer journey, as it tackles the tumours head on while helping to preserve quality of life and psychological wellbeing at the same time.

Speaking to the news source, Amethyst Group director Dr Paul Stuchetz said:

“Amethyst Radiotherapy Austria stands out as a leading private practice in the field of radiation oncology, thanks to its interdisciplinary approach, dedication to quality and innovation in diagnostics and treatment, as well as its focus on patient comfort and wellbeing.

With exceptional dedication in the application of radiotherapy and radiooncology in the treatment of oncology patients, the Amethyst Centre in Vienna boasts an expert network of specialist doctors and a modern, well-equipped facility.”

Comprehensive Care for International Patients

Welcoming patients from overseas for treatment involves following defined and structured procedures to ensure that the patient experience is safe and efficient, while remaining fully compliant with all relevant regulations and prioritising medical safety at all times.

Patient cases are looked at individually by a team of medical experts, a multidisciplinary approach that involves surgeons, radiation therapists, physicists and oncologists. Other departments are also involved to ensure that patient mental and emotional health and wellbeing is protected, including integrative therapies and psychological support.


Support for Serbian Patients

For Serbian patients interested in finding out more about how the centre could help them throughout their cancer journey, Dr Stuchetz advised them to get in touch with associate Maja Zakarija (+381 63 388 546), who will be able to provide them with all the necessary support in their native language.

Amethyst Radiotherapy Austrai David on Precision Tumour Care

Transforming Cancer Treatment in Austria—With Precision and Compassion

At Amethyst Radiotherapy Austria, we understand that a cancer diagnosis can be life-changing—for both patients and their families. That’s why we are committed to delivering fast, accurate, and non-invasive treatment using state-of-the-art radiosurgery technologies, supported by a compassionate, patient-first approach. As part of the 30th anniversary celebrations at Wiener Privatklinik (WPK), Dr David was invited to speak about our pivotal role in shaping the future of tumour care in Austria.

 

Watch the full interview to hear Dr David share how we integrate innovation, medical expertise, and patient care to improve lives.

 

Why Patients Choose Amethyst Radiotherapy Austria

Our centre specialises in stereotactic radiosurgery (SRS)—a technique that delivers precisely focused radiation to tumours while minimising exposure to surrounding healthy tissue. This advanced, non-invasive alternative to traditional surgery avoids the need for incisions, hospitalisation, or prolonged recovery.

As Dr David outlines, our approach to care is built on four key pillars:

    • Pinpoint Tumour Location
      We use advanced diagnostic imaging systems—including MRI, CT, and PET scans—to map tumours with millimetre-level accuracy.
    • Non-Invasive Treatment Delivery
      Our Elekta Versa HD linear accelerator delivers highly targeted radiation without any surgical intervention.
    • Rapid Access to Treatment
      With no long waiting lists, we offer same-day consultation and treatment planning, ensuring timely care.
    • Tailored Treatment Pathways
      Each patient benefits from a personalised care plan, based on their specific diagnosis and medical needs.

 

Our Centre Within WPK, Powered by Amethyst

Situated within Wiener Privatklinik (WPK)—Austria’s only private hospital—Amethyst Radiotherapy Austria merges WPK’s exceptional clinical environment with Amethyst’s expertise in advanced, non-invasive tumour care. As part of the Amethyst Healthcare Group—one of Europe’s largest and most experienced radiotherapy providers—we deliver internationally recognised cancer care standards with the personalised attention of a local specialist team.

 

Take the Next Step Towards Personalised Cancer Care

We are committed to offering bespoke cancer treatment tailored to each individual’s needs. From initial consultation to treatment and follow-up, every stage is guided by precision, compassion, and efficiency. Combining medical innovation with human understanding, our expert team provides rapid access to trusted, non-invasive tumour care in a calm, professional, and supportive environment you can rely on.

multidisciplinary holistic approach - cancer survivor with positive attitude

Following a diagnosis of cancer, the priority of your care team will be to ensure you get the most effective treatment possible to preserve the highest quality of life, using a multidisciplinary holistic approach shaped by advanced research.

In the vast majority of cases, as long as you attend every treatment, ensure you have enough rest and take into account the potential effects of treatment, you will still be able to enjoy your day-to-day life, keep active and even potentially go on holiday.

With summer fast approaching, alongside brighter sunny days, we are often asked how to enjoy the sun safely whilst undertaking cancer treatment, whether it is simply spending some time being active outside or taking a longer trip to relax the mind and soothe the soul.

Here are some top tips for enjoying yourself and staying safe on sunny days whilst undergoing cancer treatment.

Ask Your Cancer Team About Sun Sensitivity

Cancer treatments will affect your body and especially your skin in different ways, and exposure to the sun can potentially make you more vulnerable than usual to damage from the ultraviolet rays of the sun.

Your multidisciplinary team will be best placed to explain if any of the medications you are taking, the chemotherapy course or radiotherapy treatment would affect your ability to stay out in the sun, as exposure can sometimes exacerbate certain skin issues without protection.

Other medications taken to manage side effects, such as diuretics (used to treat water retention that can occur during some types of chemotherapy), can also increase the risk of heat issues, such as exacerbating dehydration or affecting the body’s ability to regulate heat.

As well as this, swimming can sometimes be an excellent way to stay cool, but radiotherapy can sometimes lead to an increased sensitivity to chlorine and other chemicals used to keep pools hygienic, so it is always important to ask your doctor first.

Stay In The Shade And Cover Up

Lightweight, long-sleeved loose clothes are ideal for wearing when out in the sun, as they will help to protect your arms, legs and the back of your neck from exposure whilst not being so tight and warm as to cause excessive sweating and dehydration.

This includes wearing long-sleeved shirts, loose trousers or long dresses and a summer scarf.

Similarly, wearing sunglasses will help avoid issues if your eyes have become more light-sensitive, and a hat with a wide brim can help cover the rest of your face.

Clothing is available with an ultraviolet protection factor and they would be recommended if you want to protect yourself as much as possible.

Try to avoid direct sunlight if you can, especially between 10am and 4pm when the sun is highest in the sky. It is typically best to stay in the shade, either enjoying indoor activities or underneath a sun shelter.

Wear High-SPF Sunscreen And Frequently Reapply

It is always especially important to apply a broad-spectrum high-SPF sunscreen on sunny days, but it is especially important to ensure you have complete coverage if you have been undertaking radiotherapy treatment.

Do not use an aerosol sunscreen, as it will not provide a thick enough layer of protection and could be patchy in its application. Pump sprays, lotions and roll-on applicators are far more consistent.

Apply generous amounts evenly to any exposed skin or any skin likely to be exposed during the day, such as if you plan to go swimming.

Consistently reapply, even if the product says that it is water resistant or a “once-a-day” product. Over the day, sunscreen can easily sweat away or be washed off if you go swimming.

Keep Hydrated

Hydration is vital over the summer, but this is especially important as some prescription medications can require you to drink more water and it will help to avoid tiredness and confusion.

Carry a water bottle with you and regularly take sips from it during the day, as often as you need. It is worth checking to see if a water refilling station is nearby to ensure that you do not run out.

It may be beneficial to mix your water with an electrolyte powder, as sweating caused by both the sun and physical exertion can cause you to not only lose water but also electrolyte minerals such as magnesium and potassium.

This will help you maintain not only your hydration but also your energy levels.

However, it is important to avoid alcohol or caffeine; both are diuretics that will cause further dehydration, and alcohol can affect the body’s ability to regulate temperature safely and effectively.

Radiotherapy centre - woman with drip

The development of radiotherapy and other cancer treatments has been a literal life-saver for millions of people down the years and may be even more so in the years ahead. However, a major question will be whether such developments will be sufficient to combat an expected rise in cancer incidences across Europe.

At any given time in history, some factors have played a larger role than others in causing cancer and also affecting the prospects for patients. Indeed, some factors have declined; better awareness of the dangers of smoking has led to fewer people using tobacco, while an understanding of the risks of sunburn is important in cutting skin cancer.

How Are Cancer Rates In Europe Expected To Change?

Despite this, the number of cancer cases is expected to increase in the years ahead. The European Cancer Information System (ECIS) produced a projection in 2022 that estimated the number of incidences of non-melanoma skin cancer would rise from 2.74 million to 3.25 million by 2040.

What was clear from the data was that ‘demographic change’ was expected to account for just about all of the increase, which would be definition rule out other factors such as a rebound in smoking rates, or new emerging lifestyle or pollution factors.

Part of that demographic change may be due to rising populations, although Europe’s low fertility rate means that the population would drop without immigration. However, another factor is age, because as people live longer, they become more prone to cancer.

Variations Between Countries

What was perhaps most notable was the high level of variation in the figures. The expected increase in cancer rates is 18.39 per cent across the 27 EU states. But this varies from a rise of just two per cent in Latvia to 56.8 in Luxembourg. Here in Austria, the projected figure is 23.1 per cent.

It may be asked whether variations in demographics can account for such disparities between countries. However, there could be some factors that have a significant impact.

For instance, when it comes to changing demographics, race can have a significant impact on cancer rates. For example, black men are much more likely to get prostate cancer than white men. By contrast, however, global studies indicate that black women have a lower incidence of breast cancer than white women.

This may mean that differing changes to the ethnic profiles of countries can have some impact on cancer rates. So too might variations in average age. However, it is notable that Italy, currently the oldest country in Europe, faces a projected increase in cancer rates close to the mean figure for the EU as a whole.

How New Developments In Radiotherapy Will Help

Whatever the cause of rising cancer rates, the challenge for oncologists and researchers in the field has always been to advance treatments. Radiotherapy has already come a long way since it was first used as a palliative treatment at the start of the 20th century.

Some of the most recent developments offer real hope for patients, enabling our radiotherapy centre to offer patients cutting-edge treatments.

For example, the use of FLASH, a form of proton beam radiotherapy, has been made possible in recent years by the development of means of measuring and standardising the absorbed dose of radiation in such a procedure.

This breakthrough in the UK was followed by the first clinical trials in the American city of Cincinnati in 2020, with positive results emerging in 2023. Proton beam therapy is particularly effective in directing radiation at tumours while leaving surrounding tissue almost completely untouched.

In March this year, Cancer Network highlighted another development in radiation oncology, the realm of theranostics, a form of treatment that uses radioisotopes to image tumours for diagnostic purposes as well as treat them.

The article noted that in the United States, to date, just two of these therapies have been approved, for prostate and neuroendocrine tumours, but it is likely several more could follow for other conditions.

The Importance Of Artificial Intelligence

As well as new forms of treatment, the capacity to measure and calibrate radiation doses and predict the impact of these in terms of toxicity for patients (with the consequent side-effects) is another area that can be advanced, thanks to artificial intelligence.

This was the conclusion of a study published in Nature Briefing: Cancer, which discussed how machine learning could help use CT scans to better detect and quantify the likelihood for each breast cancer patient of developing pulmonary fibrosis, a potential downside of irradiation of the breast.

What all this indicates is that while the incidences of cancer are expected to rise across Europe (albeit at a very uneven rate), the last few years have seen a range of developments that mean radiotherapy is increasingly available in new and more effective forms.

Consequently, the prospect of radiotherapy producing ever better patient outcomes is very well founded.

Oncology Patients - radiotherapy

New Amethyst Radiotherapy associate Dr Slavisa Tubin – a radiation oncology specialist – has been working on an innovative method of partial tumour irradiation with ultra-high doses, dubbed the radiovaccine because it helps to activate the immune system in the fight against tumours.

In an article for Serbian news outlet Kurier, Dr Tubin explained that his particular speciality is stereotactic body radiotherapy, as well as proton and carbon-ion radiotherapy, which are the most effective forms of radiotherapy treatment available.

These techniques have the potential to eradicate tumours completely, with low and acceptable risks of collateral effects, and patients found to tolerate treatments very well without compromising their quality of life.

Where tumours are large and unresectable (and thus unsuitable for these methods), Dr Tubin’s radiovaccine technique (developed following years of pre-clinical and clinical scientific research) allows for the addition of radiation’s anti-tumour effect to the synergistic immune anti-tumour effect, to help improve therapy results.

The aim of the radiovaccine method, where ultra-high doses of irradiation are administered, is to activate the patient’s immune system to help it fight against tumours, potentially improving positive health outcomes as a result.

Radiotherapy treatments

Radiotherapy (also referred to as radiation) involves directing a high dose of radiation at the cancer site to damage the DNA of tumour cells and disrupt blood flow to the tumour itself. This prevents further growth and reproduction of malignant cells, stopping the tumour in its tracks.

Patients first visit the Amethyst centre for an initial assessment, where a CT and MRI are taken to plan and simulate the treatment.  Dr Tubin then works with a medical physicist to devise a radiation plan, after which the therapy can begin.

Nearly all types of tumours can be treated in this way, with Dr Tubin focusing particularly on tumours of the lung, the liver, rectum and pancreas, where his specialty is large, complex and inoperable tumours.

He went on to explain that every case is unique and, as such, must be evaluated individually in order to determine the most accurate prognosis and to decide upon the most appropriate therapeutic strategy.

At radiotherapy centre Amethyst Austria, we pioneer innovative ways of working to kill and eliminate malignant tumour cells while preserving the surrounding healthy tissue. If you’d like to find out more, get in touch with the team today.

Dr David Kuczer Recognised in TREND Magazine for Cancer Care Leadership

Leading a New Era in Private Radiotherapy

At Amethyst Radiotherapy Austria, we believe every patient deserves not just precise and effective cancer treatment — but one that is delivered without delay, with compassion, and with respect for individual needs.

This commitment was recently highlighted in TREND Magazine, where Dr David Kuczer, Radiation Oncologist at our Vienna clinic, spoke about the power of private radiotherapy to transform lives.

“Every Day Matters” – Speed Can Save Lives

In the article, Dr Kuczer shared a compelling example of an elderly woman diagnosed with advanced brain metastases who contacted the clinic on Thursday. By Friday, her scans had been reviewed and a personalised treatment plan was ready. She began hippocampus-sparing radiotherapy the following Monday — a technique that helps preserve memory while treating the brain.

Dr Kuczer emphasised the urgency of the case, explaining that the metastases were dangerously close to blocking fluid flow in the brain: “A delay could have been fatal,” he said, underscoring his philosophy that “every day matters.”

What Sets Amethyst Austria Apart?

In the article, Dr Kuczer highlighted the following unique characteristics that set Amethyst Austria apart:

  • Fast and personalised treatment: Dr Kuczer shares a case of a patient who received a full treatment plan and began hippocampus-sparing radiotherapy within four days of diagnosis.
  • Access to cutting-edge technology: The centre is equipped with the Elekta Versa HD linear accelerator, enabling highly targeted therapy supported by advanced imaging.
  • Multidisciplinary tumour board: All cases are discussed by a panel of specialists to ensure optimal, collaborative decision-making.
  • Equity in private care: While Austria’s statutory insurance does not currently cover private radiotherapy, Dr Kuczer notes that affordability is a priority, with flexible options offered in hardship cases and referrals to public hospitals where appropriate.
  • Challenges in public healthcare: Reflecting on his previous hospital roles, Dr Kuczer outlines the systemic strains facing the public sector — including staffing shortages and administrative barriers — which ultimately influenced his move to fully private practice.

Why Dr Kuczer Chose Private Practice

Having trained at Charité Berlin and worked in Austria’s public healthcare system, Dr Kuczer witnessed the increasing pressure: understaffing, treatment delays, and growing patient frustration. He transitioned into private care to offer something different.

“I wanted to build a place where people are treated not just for their disease — but as whole human beings. With urgency, dignity, and care.”

This vision is now embedded in the day-to-day practice at Amethyst Austria — where clinical precision is matched by speed, empathy, and a deeply personal approach to every case. Patients are no longer left waiting in fear; instead, they are met with timely action and a team that sees them as more than just a diagnosis.

📖 Read the full article in the May 2025 issue of TREND Magazine HERE.


At Amethyst Austria, we combine speed, precision, and compassion to deliver the highest standard of cancer care — without the wait. Contact us today to learn more or book a consultation.

non-malignant diseases - spine pain of man

Radiotherapy is commonly seen as a curative treatment, used in targeted high doses to treat conditions such as cancer, tumours or sarcomas.

However, low doses of radiation are also often used to treat non-malignant diseases and help manage chronic pain disorders with a series of painless, quick, unobtrusive treatments.

It is provably effective and safe for many people, but how does it work and what types of conditions can it help treat?

How Does Low-Dose Radiotherapy Work?

Broadly defined, low-dose radiotherapy is any type of radiotherapy designed to alleviate symptoms and manage pain rather than cure a disease or destroy a tumour.

Whilst it can and often is used as part of palliative cancer care to relieve symptoms rather than treat the disease, it can be used to take care of a wide range of conditions which are caused by inflammation, pressure or the stiffness of joints.

Low-dose radiotherapy is still highly targeted, but due to the lower doses of radiation does not take as much time in the treatment centre, nor does it have the same side effects.

Typically, a low-dose radiotherapy treatment takes seconds and is almost always painless. If there is an expectation of pain as part of the response to treatment, your radiotherapist will explain it to you, but that tends to be rare, and recovery is very quick.

It is also a relatively old treatment; for as long as radiotherapy has existed at all, it has been used to help relieve certain non-malignant conditions such as lupus as early as the late 1890s, and low-dose X-ray therapy has been widely used in Austria and Germany for decades to help ease pain.

How Is Radiotherapy Used To Treat Arthritis?

One of the most widespread and effective uses of low-dose radiotherapy is in the treatment of osteoarthritis, the most common type of arthritis in Austria and other parts of Europe.

There are various types of osteoarthritis, which can cause pain, sensitivity, swelling and noticeable sounds when moving joints, but if they are causing particular issues with mobility or day-to-day living, radiotherapy might be an option.

It is typically recommended if other more conservative treatments have not been effective. Light exercise, physiotherapy, resting or topical medications are often recommended or prescribed for a few months, but if they are not helping to ease symptoms, radiotherapy may be the best option.

It is typically provided in six to eight targeted low doses over two to three weeks in sessions that last less than ten minutes each. The radiotherapy itself takes less than a minute and can, in some cases, take less than ten seconds due to the low doses and lower risk involved in their use.

We specialise in using low-dose radiotherapy to treat osteoarthritis in the hip, knee, shoulder, finger and thumb joints, in order to ease pain, relieve swelling, reduce pressure and improve their range of motion.

What Else Can Low-Dose Radiotherapy Be Used For

Besides reducing osteoarthritis, it can be used to help with shoulder, elbow and forearm pain, relieving soreness in areas of the arms with larger amounts of soft tissue, as well as treat a range of benign, non-malignant but nevertheless still uncomfortable diseases.

Prophylaxis For Gynecomastia

This includes its use as a prophylaxis to reduce the risk of developing gynecomastia, a disorder where men develop larger breasts, typically caused by hormonal imbalances.

It is typically used before hormone therapy to make it more effective in reducing symptoms and preventing the development of breast tissue, as well as relieving pain around the chest.

Reducing Keloid Scars

Some people are at an increased risk of developing keloid scars, where a thicker, larger scar grows over a wound, which can be itchy or painful whilst it is growing and potentially affect joint movement depending on where it grows.

It cannot be removed by surgery, as that creates a bigger wound and potentially a bigger scar, but radiotherapy can help once the scar has been surgically removed in order to keep it away, particularly if cryotherapy, laser therapy or steroid treatments cannot be used.

Ledderhose And Dupuytren’s Disease

A condition caused by the thickening of connective tissue, the differences between Dupuytren’s disease and Ledderhose disease are that the lumps and nodules grow on the palm or on the base of the foot, respectively.

Radiotherapy can help in the early stages to stop the nodules from growing and avoid the need for surgery on the hand or foot should the condition continue to progress.

It is primarily effective during the proliferation phase as a complement to physiotherapy, massages and exercises.

Cancer care provider Amethyst Austria is proud to announce that it has just been featured on BLIC, one of Serbia’s leading news platforms, showcasing the organisation’s successes in fighting cancer with radiotherapy treatments.

Located in the heart of Vienna, the radiotherapy centre works closely with a leading team of international experts to ensure that patients from all over the world receive the very best and most advanced form of cancer therapy.

The BLIC article makes special mention of Dr Alinca Sturdza, an expert in radiation oncology with a focus on gynecology, who gained her expertise at Princess Margaret University Hospital in Toronto, Canada.

She was quoted as saying: “As an expert in brachytherapy, one of the most precise forms of cancer treatment with radiation, I use the most modern methods of radiotherapy. Thanks to the constant advances in oncology, cancer is becoming a chronic disease in many cases and I’m here to support patients on that journey as best as possible.”

Radiation oncology specialist Dr David Kuczer was also a focus of the news piece, a doctor with more than 20 years of experience in highly precise radiation therapy, particularly in the treatment of cancerous lesions, including prostate and breast cancer.

At the Amethyst clinic, modern radiotherapy techniques have been designed to ensure that optimal doses of radiation are targeted towards the tumour so that minimal damage is caused to the surrounding health tissue.

We are part of a long-established network of clinics in the heart of Vienna, working with experienced partners to deliver a highly coordinated team for cancer therapy. Patients receive expert care and optimal treatment in accordance with international and national maximum standards and guidelines.

If you’d like to find out more about treatment options and how you could benefit, get in touch with the Amethyst Austria team today.

Amethyst Austria radiation oncology specialist Dr David Kuczer has given an interview to Zena, one of the leading news platforms in Serbia, discussing the role that radiotherapy has to play in the treatment of breast cancer.

He explained to the news source that individual treatment concepts are designed to suit each patient, based on the most up-to-date and innovative knowledge to ensure that optimal results are delivered, both in terms of medical and aesthetic outcomes.

Within Amethyst Austria’s Department of Tumours, the interdisciplinary team works together to devise individual approaches to patient care, with Dr Kuczer noting that from his perspective, it’s particularly important to spend time with patients as well as exchanging opinions with colleagues and discussing the various treatment options available case by case.

Approximately 50 per cent of all cancer patients will undergo radiotherapy, which involves directing high doses of radiation to tumours so that diseased cell DNA is damaged sufficiently to prevent multiplication. The tumour cells then die and are broken down by the body.

This kind of therapy means that tissue affected by the tumour can be removed, which protects the entire breast and prevents complete removal. Furthermore, the treatment works to eliminate microscopic tumour remnants to prevent recurrence.

Dr Kuczer continued, saying: “Thanks to modern technology, the therapy has been reduced from about 30 treatments during six weeks to five to 20 treatments over the course of one to four weeks, depending on the individual case. The sessions last ten minutes and are performed on an outpatient basis.”

Given that cancer is the leading cause of death worldwide, causing almost ten million fatalities each year, it’s evident that more effective treatment methods are necessary.

At Amethyst Austria, we pioneer innovative ways of working to kill and eliminate malignant tumour cells while preserving the surrounding healthy tissue. If you’d like to find out more, get in touch with the team today.

novocure technology - Cancer Patient on a Wheelchair

Because there are hundreds of different cancer types, there are a huge number of treatments, some of which are better suited to certain kinds of cancer than others.

However, whilst there are three main types of treatment in surgery, chemotherapy and radiotherapy, a fourth approved treatment type known as Novocure has demonstrated considerable promise as a potentially versatile therapy.

Because Novocure and similar tumour treating fields (TTFields) treatments are still relatively new, the range of tumour types they can treat is still the subject of significant medical study.

Here is what is known so far, and what you should know if you and your doctor think it might be the right treatment for you.

What Is Novocure?

Novocure, or the broader treatment type of tumour treating fields, is an alternating electric field therapy where low-intensity electric fields are used to disrupt the division of cancer cells, which leads to cell death and potentially shrinking or destroying tumours in the process.

By placing electrode arrays on the skin near where a tumour is located, a TTFields treatment tuned to a certain frequency could interfere with the structure of cell division and destroy them as they attempt to multiply.

Whilst more research is being undertaken as to the exact process, the system has been approved because TTFields treatments are non-invasive and potentially cause less harm to healthy cells than alternative treatments.

Why Is It Different From Radiotherapy?

In principle, TTFields works towards a broadly similar goal to radiotherapy, although the methodology and treatment process is often very different.

Radiotherapy works by using targeted radioactive beams to destroy cancerous cells, but radiation can also harm healthy cells.

This is why treatments such as Gamma Knife radiosurgery use extensive planning processes and fixed frames to precisely deliver doses of radiation. As its inventor, Lars Leksell put it, there is no tool too precise for use in the brain.

Whilst chemotherapy uses a different process, it is similar to radiotherapy in that whilst it damages cancer cells, it also affects other cells as well.

This is something that TTFields therapies manage to avoid, allowing for a non-invasive type of treatment without many expected side effects.

When Is It Used?

At present, TTFields therapy is primarily used to treat glioblastoma and mesothelioma, cancer types that can be difficult to treat without aggressive treatment, as this can allow for a higher quality of life during treatment than intense chemotherapy or surgery will allow.

Treating mesothelioma, a cancer that affects the lining of the lungs and heart which is often associated with asbestos exposure, is not always easy as it is often resistant to radiotherapy.

A TTFields treatment in this case is typically provided alongside chemotherapy in order to make the latter more effective; a 2025 study in the American Journal of Cancer Research suggested that it forced cancer cells to absorb more chemotherapy medicine and stopped cancer cells from dividing.

On the other hand, glioblastoma is an aggressive form of brain tumour that is commonly treated using a combination of surgery and complementary radiotherapy and chemotherapy to reduce the potential for it to return or to treat recurrent cases without invasive radical treatments.

A lot of research is currently being undertaken to ascertain its applicability for a range of other types of cancer as well, with some promise being found in trials of its use to treat certain types of pancreatic cancer.

Is It Right For You?

Your oncologist and multidisciplinary team will explore the possibility of using Novocure, as the innovative treatment type can not only improve the overall rate of survival but can do so whilst providing a high quality of life and level of control over treatment.

A TTFields therapy is noninvasive and is simply worn on the body. There is no need for surgery, no injections and little disruption besides shaving the hair on the part of the body where electrodes are applied and mild skin irritation in some cases.

There are typically fewer appointments required or regimented sessions, unlike the daily radiotherapy sessions or stays in hospital needed for surgery.

It also does not necessarily cause the same levels of fatigue that some aggressive forms of treatment can cause, allowing people to continue living their lives and maintaining their independence.

We understand the importance of having a routine and the ability to enjoy your time with loved ones or doing what you love, and Novocure TTFields therapy can allow you to receive vital treatment without the major disruptions that can sometimes come with it.